BioTime awarded 14 new patents

|By:, SA News Editor

BioTime (NYSEMKT:BTX) reports that it was been awarded 14 new patents in Australia, Canada, China, Japan and the U.S. The company now has over 600 existing patents and patent applications in the field of pluripotent stem cell technology.